Follow Us
Disclosure
In accordance with the EFPIA Code, Varnavas Hadjipanayis Ltd is required to document and publicly disclose any Transfers of Value made directly or indirectly to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs).
Such disclosure takes place in order to ensure transparency in the dealings between pharmaceutical companies and HCPs and HCOs.
Disclosure and publication of transfers of value will take place on an annual basis starting from 2016 for the transfers made during the year 2015.
2015
Download Disclosure Code_Janssen_2015.pdf
2016
Download Disclosure Code_Janssen_2016.pdf
2017
Download Disclosure Code_Janssen_2017.pdf
2018
Download Disclosure Code_Janssen_2018.pdf
2019
Download Disclosure Code Janssen 2019.pdf
2020
Download Disclosure 2020_JANSSEN.pdf
2021
Disclosure-Code-Schedule-2-Janssen 2021 - Final.xlsx
2022
Download Disclosure-Code-Janssen_2022.docx
2015
Download Disclosure Code_Novo_2015.pdf
2016
Download Disclosure Code_Novo Nordisk_2016.pdf
2017
Download Disclosure Code_Novo Nordisk_2017.pdf
2018
Download Disclosure Code_Novo Nordisk_2018.pdf
2019
Download Disclosure Code Novo Nordisk 2019.pdf
2020
Download Disclosure 2020_Novo Nordisk.pdf
2021
Download Disclosure-Code-NovoNordisk_2021- Final.xlsx
2022
Download Disclosure-Code-NovoNordisk_2022.xlsxx
2017
Download Disclosure Code_CSL_2017.pdf
2018
Download Disclosure Code_CSL_2018.pdf
2019
Download Disclosure Code CSL 2019.pdf
2020
Download Disclosure 2020_CSL.pdf
2021
Download Disclosure-Code-Schedule-2-CSL 2021 - Final.xlsx
2022
Download Disclosure-Code-CSL Behring_2022.docx